Paper Details

  1. Home
  2. Paper Details

Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.

Author: BengtssonBo, HeijlAnders, HymanLeslie, KomaroffEugene, LeskeM Cristina

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

The review summarizes factors that contribute to progression in early glaucoma, including the effect of treatment, based on the Early Manifest Glaucoma Trial (EMGT) data.
Paper Details　
Original Abstract of the Article :
This review summarizes factors for progression in the Early Manifest Glaucoma Trial (EMGT), including the effect of treatment. EMGT randomized patients with early glaucoma either to argon laser trabeculoplasty plus betaxolol (n = 129) or to no immediate treatment (n = 126) and followed them every 3 ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00055735-200404000-00008

データ提供：米国国立医学図書館（NLM）

Factors Influencing Glaucoma Progression: Insights from the Early Manifest Glaucoma Trial

The [Early Manifest Glaucoma Trial (EMGT)] aimed to understand the factors that contribute to [glaucoma progression], a serious eye condition that can lead to blindness. This study compared the effects of [argon laser trabeculoplasty plus betaxolol] treatment versus no immediate treatment in patients with early glaucoma. The researchers followed these patients over time to observe the progression of their condition. The EMGT provides valuable data on the potential benefits of early intervention and the factors that influence disease progression.

Early Intervention: A Key to Managing Glaucoma

The EMGT demonstrates the importance of early intervention in managing glaucoma. Patients who received treatment experienced a slower progression of the disease compared to those who did not. This suggests that early intervention can significantly impact the long-term health of the eye and prevent irreversible vision loss. The study also highlights the need to understand the individual factors that influence disease progression in order to tailor treatment plans and improve outcomes.

Protecting Your Eyes: Early Detection and Treatment

This research emphasizes the importance of regular eye exams, particularly for individuals at risk for glaucoma. Early detection and treatment can significantly reduce the risk of vision loss. It's important to be proactive about your eye health and consult an eye doctor if you have any concerns. As the saying goes, "Prevention is better than cure," and this research shows that early intervention can make a real difference in protecting your vision.

Dr.Camel's Conclusion

The EMGT, like a guiding star in the night sky, shines a light on the importance of early intervention in managing glaucoma. This research, like a camel navigating the vast desert, reminds us of the importance of proactively addressing eye health and seeking professional care.

Date :
  1. Date Completed 2004-05-25
  2. Date Revised 2019-10-26
Further Info :

Pubmed ID

15021220

DOI: Digital Object Identifier

10.1097/00055735-200404000-00008

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.